Julie Rubinstein

Insider Reports History

Entity
Individual
Location
C/O Adaptive Biotechnologies Corporation, 1551 Eastlake Ave E Ste 200, Seattle, WA
Signature
/s/ Julie Rubinstein by Kyle Piskel, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Julie Rubinstein:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Adaptive Biotechnologies Corp President and COO Common Stock 588K $4.11M $6.99 Mar 5, 2025 Direct

Insider Reports Filed by Julie Rubinstein

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ADPT Adaptive Biotechnologies Corp Mar 4, 2025 3 -$416K 4 Mar 6, 2025 President and COO
ADPT Adaptive Biotechnologies Corp Mar 4, 2024 3 -$136K 4 Mar 6, 2024 President
ADPT Adaptive Biotechnologies Corp Mar 6, 2023 3 -$194K 4 Mar 8, 2023 President
ADPT Adaptive Biotechnologies Corp Mar 4, 2022 3 -$55.4K 4 Mar 8, 2022 President